Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Factor structure and psychometric properties of the TFEQ in morbid obese patients, candidates to bariatric surgery.

Taboada D, Navío M, Jurado R, Fernández V, Bayón C, Álvarez MJ, Morales I, Ponce G, Rubio G, Mingote JC, Cruz F, Jiménez MA.

Psicothema. 2015 May;27(2):141-50. doi: 10.7334/psicothema2014.46.

PMID:
25927694
2.

Comparing methods of determining Legionella spp. in complex water matrices.

Díaz-Flores Á, Montero JC, Castro FJ, Alejandres EM, Bayón C, Solís I, Fernández-Lafuente R, Rodríguez G.

BMC Microbiol. 2015 Apr 29;15(1):91. doi: 10.1186/s12866-015-0423-7.

3.

The psychosocial response to the ebola health emergency: experience in madrid, Spain.

Rodríguez-Vega B, Amador B, Ortiz-Villalobos A, Barbero J, Palao A, Avedillo C, Alcami M, García-Benito P, Fernandez-Sanchez A, Perez-Sales P, Bayón C, Cebolla S, Bravo Ortiz MF.

Clin Infect Dis. 2015 Jun 15;60(12):1866-7. doi: 10.1093/cid/civ173. Epub 2015 Mar 3. No abstract available.

PMID:
25737372
4.

Facial emotional processing deficits in long-term HIV-suppressed patients.

Gonzalez-Baeza A, Perez-Valero I, Carvajal-Molina F, Bayon C, Montes-Ramirez M, Bernardino JI, Arribas JR.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19664. doi: 10.7448/IAS.17.4.19664. eCollection 2014.

5.

A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral therapy.

Estébanez M, Stella-Ascariz N, Mingorance J, Pérez-Valero I, González-Baeza A, Bayón C, Lakatos B, Borobia A, Arnalich F, Arribas JR.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):419-23. doi: 10.1097/QAI.0000000000000337.

PMID:
25197825
6.

Mindfulness-based cognitive therapy versus psychoeducational intervention in bipolar outpatients with sub-threshold depressive symptoms: a randomized controlled trial.

Lahera G, Bayón C, Fe Bravo-Ortiz M, Rodríguez-Vega B, Barbeito S, Sáenz M, Avedillo C, Villanueva R, Ugarte A, González-Pinto A, de Dios C.

BMC Psychiatry. 2014 Aug 15;14:215. doi: 10.1186/s12888-014-0215-x.

7.

A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals.

Pérez-Valero I, González-Baeza A, Estébanez M, Monge S, Montes-Ramírez ML, Bayón C, Pulido F, Bernardino JI, Zamora FX, González-García JJ, Lagarde M, Hernando A, Arnalich F, Arribas JR.

Clin Infect Dis. 2014 Dec 1;59(11):1627-34. doi: 10.1093/cid/ciu640. Epub 2014 Aug 11.

PMID:
25114032
8.

Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada.

Robertson K, Bayon C, Molina JM, McNamara P, Resch C, Muñoz-Moreno JA, Kulasegaram R, Schewe K, Burgos-Ramirez A, De Alvaro C, Cabrero E, Guion M, Norton M, van Wyk J.

AIDS Care. 2014;26(12):1555-61. doi: 10.1080/09540121.2014.936813. Epub 2014 Jul 16.

9.

New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy.

Treviño J, Bayón C, Ardá A, Marinelli F, Gandolfi R, Molinari F, Jimenez-Barbero J, Hernáiz MJ.

Chemistry. 2014 Jun 10;20(24):7363-72. doi: 10.1002/chem.201303310. Epub 2014 May 7.

PMID:
24805824
10.

Wavelength-tunable light shaping with cholesteric liquid crystal microlenses.

Bayon C, Agez G, Mitov M.

Lab Chip. 2014 Jun 21;14(12):2063-71. doi: 10.1039/c4lc00152d. Epub 2014 May 2.

PMID:
24789329
11.

Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: a detailed neuropsychological study.

González-Baeza A, Carvajal F, Bayón C, Pérez-Valero I, Estébanez M, Bernardino JI, Monge S, Lagarde M, Hernando A, Arnalich F, Arribas JR.

J Neurovirol. 2014 Aug;20(4):362-70. doi: 10.1007/s13365-014-0251-9. Epub 2014 Apr 24.

PMID:
24760361
12.

Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.

del Campo R, Garriga M, Pérez-Aragón A, Guallarte P, Lamas A, Máiz L, Bayón C, Roy G, Cantón R, Zamora J, Baquero F, Suárez L.

J Cyst Fibros. 2014 Dec;13(6):716-22. doi: 10.1016/j.jcf.2014.02.007. Epub 2014 Mar 11.

PMID:
24636808
13.

Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy.

Pérez-Valero I, González-Baeza A, Estébanez M, Montes-Ramírez ML, Bayón C, Pulido F, Bernardino JI, Zamora FX, Monge S, Gaya F, Lagarde M, Rubio R, Hernando A, Arnalich F, Arribas JR.

PLoS One. 2013 Jul 25;8(7):e69493. doi: 10.1371/journal.pone.0069493. Print 2013.

14.

Endocrine and inflammatory profiles in type 2 diabetic patients with and without major depressive disorder.

Alvarez A, Faccioli J, Guinzbourg M, Castex MM, Bayón C, Masson W, Bluro I, Kozak A, Sorroche P, Capurro L, Grosembacher L, Proietti A, Finkelsztein C, Costa L, Fainstein Day P, Cagide A, Litwak LE, Golden SH.

BMC Res Notes. 2013 Feb 14;6:61. doi: 10.1186/1756-0500-6-61.

15.

Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey.

Lasalvia A, Zoppei S, Van Bortel T, Bonetto C, Cristofalo D, Wahlbeck K, Bacle SV, Van Audenhove C, van Weeghel J, Reneses B, Germanavicius A, Economou M, Lanfredi M, Ando S, Sartorius N, Lopez-Ibor JJ, Thornicroft G; ASPEN/INDIGO Study Group.

Lancet. 2013 Jan 5;381(9860):55-62. doi: 10.1016/S0140-6736(12)61379-8. Epub 2012 Oct 18. Erratum in: Lancet. 2015 Jan 24;385(9965):330.

PMID:
23083627
16.

Prevalence of depressive and other central nervous system symptoms in HIV-infected patients treated with HAART in Spain.

Bayón C, Ribera E, Cabrero E, Griffa L, Burgos Á.

J Int Assoc Physicians AIDS Care (Chic). 2012 Sep-Oct;11(5):321-8. Epub 2012 Jun 19.

PMID:
22713685
17.

Overexpression of the sterol 14α-demethylase gene (MgCYP51) in Mycosphaerella graminicola isolates confers a novel azole fungicide sensitivity phenotype.

Cools HJ, Bayon C, Atkins S, Lucas JA, Fraaije BA.

Pest Manag Sci. 2012 Jul;68(7):1034-40. doi: 10.1002/ps.3263. Epub 2012 Mar 12.

PMID:
22411894
18.

Risk assessment studies on succinate dehydrogenase inhibitors, the new weapons in the battle to control Septoria leaf blotch in wheat.

Fraaije BA, Bayon C, Atkins S, Cools HJ, Lucas JA, Fraaije MW.

Mol Plant Pathol. 2012 Apr;13(3):263-75. doi: 10.1111/j.1364-3703.2011.00746.x. Epub 2011 Sep 20.

PMID:
21933337
19.

Differences in depressed oncologic patients' narratives after receiving two different therapeutic interventions for depression: a qualitative study.

Rodríguez Vega B, Orgaz Barnier P, Bayón C, Palao A, Torres G, Hospital A, Benito G, Dieguez M, Fernández Liria A.

Psychooncology. 2012 Dec;21(12):1292-8. doi: 10.1002/pon.2036. Epub 2011 Sep 1.

PMID:
21882288
20.

Protease inhibitor monotherapy and the CNS: peace of mind?

Perez-Valero I, Bayon C, Cambron I, Gonzalez A, Arribas JR.

J Antimicrob Chemother. 2011 Sep;66(9):1954-62. doi: 10.1093/jac/dkr229. Epub 2011 Jun 13. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk